Pelvic Floor Therapies for Lifelong Premature Ejaculation

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexMale
Age18-50
SponsorTanta University

About this trial

This randomized controlled trial will compare three pelvic floor-based treatment modalities in men with lifelong premature ejaculation: electromagnetic pelvic floor stimulation, biofeedback-assisted pelvic floor muscle training, and conventional pelvic floor muscle training. A total of 150 men aged 18 to 50 years with lifelong premature ejaculation and stopwatch-measured intravaginal ejaculatory latency time of less than 1 minute will be randomly assigned to one of the three treatment groups. The primary outcome will be the change in intravaginal ejaculatory latency time from baseline to the end of treatment at 6 weeks. Secondary outcomes will include changes in Premature Ejaculation Diagnostic Tool score, International Index of Erectile Function-5 score, patient-reported ejaculatory control, sexual satisfaction, partner satisfaction, treatment adherence, and adverse events.

Eligibility criteria

Qualifiers

Men aged 18 to 50 years.

Diagnosis of lifelong premature ejaculation.

Intravaginal ejaculatory latency time less than 1 minute.

Ability and willingness to comply with the treatment protocol and follow-up visits.

Disqualifiers

Erectile dysfunction.

Neurological disease.

Previous pelvic surgery.

Trial design

Treatments tested in this trial

  • Electromagnetic Pelvic Floor Stimulation
  • Biofeedback-Assisted Pelvic Floor Muscle Training
  • Conventional Pelvic Floor Muscle Training

Treatment groups

150 Participants
are divided into 3 treatment groups

Sponsors and collaborators